CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-30 | Taylor Stacy L SVP and General Counsel | Option exercise · Stock Option (Right to Buy) | −1,354 | 46,042 | ||
| 2021-04-22 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +7,790 | $6.32 | $49K | 77,150 |
| 2021-04-22 | ROBINS HARLAN S Chief Scientific Officer | Sale | −4,280 | $42.85 | $183K | 72,870 |
| 2021-04-22 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,510 | $43.59 | $153K | 69,360 |
| 2021-04-22 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −7,790 | 140,220 | ||
| 2021-04-21 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +7,790 | $6.32 | $49K | 77,150 |
| 2021-04-21 | ROBINS HARLAN S Chief Scientific Officer | Sale | −500 | $39.85 | $20K | 76,650 |
| 2021-04-21 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,090 | $41.17 | $86K | 74,560 |
| 2021-04-21 | ROBINS HARLAN S Chief Scientific Officer | Sale | −5,200 | $41.79 | $217K | 69,360 |
| 2021-04-21 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −7,790 | 148,010 | ||
| 2021-04-20 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +11,685 | $6.32 | $74K | 81,045 |
| 2021-04-20 | ROBINS HARLAN S Chief Scientific Officer | Sale | −8,685 | $40.24 | $349K | 72,360 |
| 2021-04-20 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,000 | $41.35 | $124K | 69,360 |
| 2021-04-20 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,685 | 155,800 | ||
| 2021-04-19 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Option exercise | +1,301 | $22.55 | $29K | 10,459 |
| 2021-04-19 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Sale | −1,301 | $41.25 | $54K | 9,158 |
| 2021-04-19 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Option exercise · Stock Option (Right to Buy) | −1,301 | 107,647 | ||
| 2021-04-15 | LO FRANCIS Chief People Officer | Option exercise | +2,000 | $7.80 | $16K | 22,604 |
| 2021-04-15 | LO FRANCIS Chief People Officer | Sale | −2,000 | $43.04 | $86K | 20,604 |
| 2021-04-15 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (Right To Buy) | −2,000 | 153,000 |
Page 49 of 120 · 2,386 trades